Klinisk Biokemi i Norden · 1 2019
| 19
6. Kagan KO, Wright D, Spencer K, Molina
FS, Nicolaides KH. First-trimester screening
for trisomy 21 by free beta-human chorio-
nic gonadotropin and pregnancy-associated
plasma protein-A: impact of maternal and
pregnancy characteristics. Ultrasound Obstet
Gynecol 2008;31:493-502.
7. Kirkegaard I, Petersen OB, Uldbjerg N, Tor-
ring N. Improved performance of first-trime-
ster combined screening for trisomy 21 with
the double test taken before a gestational age
of 10 weeks. Prenat Diagn. 2008;28:839-44.
8. Alldred SK, Deeks JJ, Guo B, Neilson JP,
Alfirevic Z. Second trimester serum tests for
Down’s Syndrome screening. Cochrane Data-
base Syst Rev 2012:CD009925.
9. Bredaki FE, Sciorio C, Wright A, Wright D,
Nicolaides KH. Serum alpha-fetoprotein in
the three trimesters of pregnancy: effects of
maternal characteristics and medical history.
Ultrasound Obstet Gynecol. 2015;46:34-41.
10. Bodin CR, Rasmussen MM, Tabor A, West-
bom L, Tiblad E, Ekelund CK, et al. Ultra-
sound in Prenatal Diagnostics and Its Impact
on the Epidemiology of Spina Bifida in a Nati-
onal Cohort from Denmark with a Compari-
son to Sweden. Biomed ResInt 2018;9203985.
11. Gil MM, Quezada MS, Revello R, Akolekar
R, Nicolaides KH. Analysis of cell-free DNA
in maternal blood in screening for fetal aneu-
ploidies: updated meta-analysis. Ultrasound
Obstet Gynecol 2015;45:249-66.
12. Hartwig TS, Ambye L, Sorensen S, Jorgensen
FS. Discordant non-invasive prenatal testing
(NIPT) - a systematic review. Prenat Diagn
2017;37:527-39.
13. Straver R, Sistermans EA, Holstege H, Visser
A, Oudejans CB, Reinders MJ. WISECON-
DOR: detection of fetal aberrations from shal-
low sequencing maternal plasma based on a
within-sample comparison scheme. Nucleic
Acids Res 2014;42:e31.
14. Bjerregaard L, Stenbakken AB, Andersen CS,
Kristensen L, Jensen CV, Skovbo P, et al. The
rate of invasive testing for trisomy 21 is redu-
ced after implementation of NIPT. Dan Med
J 2017;64.
15. Rolnik DL, Wright D, Poon LCY, Syngelaki
A, O’Gorman N, de Paco Matallana C, et al.
ASPRE trial: performance of screening for
preterm pre-eclampsia. Ultrasound Obstet
Gynecol 2017;50:492-5.
Foto: Henrik Alfthan.
